L J Wong1. 1. Institute for Molecular and Human Genetics, Georgetown University Medical Center, Washington, DC 20007, USA.
Abstract
PURPOSE: To correlate the molecular characteristics of the mtDNA deletions with clinical phenotypes. METHODS: Southern analysis and polymerase chain reaction (PCR)/DNA sequencing were used to determine the size and location of deletions in 16 patients with mtDNA deletion syndrome. An additional 48 reported cases from the literature were also included in the statistical analysis. RESULTS: The common 5-kb deletion is found in eight of nine patients with Kearns-Sayre syndrome (KSS), mitochondrial myopathies (MM), or progressive external ophthalmoplegia (PEO). The rare/novel deletions were found in six of seven patients with extra-neuromuscular multisystemic manifestations and infantile/early childhood onset. CONCLUSIONS: Patients with mtDNA deletion syndrome who manifest non-neuromuscular multisystemic disorders at a very young age usually harbor mutant mtDNA with novel or rare deletions in every tissue analyzed. For this group of patients, it is possible to use the less invasive blood specimens instead of muscle biopsies for molecular diagnosis. Overwhelmingly, the common 5-kb deletion is mostly seen in the muscle specimens of patients with KSS and age of onset after the second decade of life.
PURPOSE: To correlate the molecular characteristics of the mtDNA deletions with clinical phenotypes. METHODS: Southern analysis and polymerase chain reaction (PCR)/DNA sequencing were used to determine the size and location of deletions in 16 patients with mtDNA deletion syndrome. An additional 48 reported cases from the literature were also included in the statistical analysis. RESULTS: The common 5-kb deletion is found in eight of nine patients with Kearns-Sayre syndrome (KSS), mitochondrial myopathies (MM), or progressive external ophthalmoplegia (PEO). The rare/novel deletions were found in six of seven patients with extra-neuromuscular multisystemic manifestations and infantile/early childhood onset. CONCLUSIONS: Patients with mtDNA deletion syndrome who manifest non-neuromuscular multisystemic disorders at a very young age usually harbor mutant mtDNA with novel or rare deletions in every tissue analyzed. For this group of patients, it is possible to use the less invasive blood specimens instead of muscle biopsies for molecular diagnosis. Overwhelmingly, the common 5-kb deletion is mostly seen in the muscle specimens of patients with KSS and age of onset after the second decade of life.
Authors: Joyce J Lee; Laura M Tripi; Richard W Erbe; Sudha Garimella-Krovi; James E Springate Journal: Pediatr Nephrol Date: 2012-01-20 Impact factor: 3.714
Authors: Kam Ming Au; Shing Chi Lau; Yuen Fun Mak; Wai Ming Lai; Tat Chong Chow; Mo Lung Chen; Man Chun Chiu; Albert Yan Wo Chan Journal: Pediatr Nephrol Date: 2006-09-12 Impact factor: 3.714
Authors: Bekim Sadikovic; Jing Wang; Ayman W El-Hattab; Megan Landsverk; Ganka Douglas; Ellen K Brundage; William J Craigen; Eric S Schmitt; Lee-Jun C Wong Journal: PLoS One Date: 2010-12-20 Impact factor: 3.240